Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytoskeletal Proteins | 2 | 2022 | 18 | 1.460 |
Why?
|
| Osteoarthritis | 5 | 2022 | 330 | 1.000 |
Why?
|
| Muscle Proteins | 2 | 2022 | 27 | 0.860 |
Why?
|
| Cartilage, Articular | 5 | 2022 | 418 | 0.860 |
Why?
|
| Chondrocytes | 3 | 2022 | 150 | 0.800 |
Why?
|
| Temporomandibular Joint | 1 | 2022 | 16 | 0.780 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2020 | 2 | 0.670 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 12 | 0.660 |
Why?
|
| Mice | 12 | 2022 | 1395 | 0.630 |
Why?
|
| beta Catenin | 1 | 2020 | 61 | 0.630 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2016 | 1 | 0.530 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 3 | 0.530 |
Why?
|
| Calcification, Physiologic | 1 | 2016 | 18 | 0.530 |
Why?
|
| Animals | 14 | 2022 | 3642 | 0.530 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 34 | 0.520 |
Why?
|
| Osteoblasts | 1 | 2016 | 55 | 0.520 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2013 | 2 | 0.430 |
Why?
|
| Fructose | 1 | 2013 | 6 | 0.430 |
Why?
|
| Sweetening Agents | 1 | 2013 | 7 | 0.430 |
Why?
|
| Hypertriglyceridemia | 1 | 2013 | 20 | 0.420 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 38 | 0.420 |
Why?
|
| Liver | 1 | 2013 | 145 | 0.390 |
Why?
|
| Mice, Knockout | 5 | 2020 | 301 | 0.360 |
Why?
|
| Lactoferrin | 3 | 2013 | 9 | 0.320 |
Why?
|
| Intervertebral Disc | 3 | 2013 | 121 | 0.290 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 219 | 0.280 |
Why?
|
| Signal Transduction | 4 | 2020 | 443 | 0.250 |
Why?
|
| Osteoclasts | 2 | 2016 | 20 | 0.250 |
Why?
|
| Aggrecans | 2 | 2022 | 56 | 0.220 |
Why?
|
| Gene Expression | 2 | 2020 | 199 | 0.180 |
Why?
|
| Phenotype | 2 | 2020 | 312 | 0.180 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 3 | 0.170 |
Why?
|
| Protein Stability | 1 | 2020 | 5 | 0.170 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 18 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 11 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 45 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 17 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 56 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2020 | 50 | 0.160 |
Why?
|
| Insulin | 1 | 2020 | 89 | 0.160 |
Why?
|
| Gene Editing | 1 | 2019 | 5 | 0.160 |
Why?
|
| Cell Proliferation | 1 | 2020 | 175 | 0.160 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 9 | 0.160 |
Why?
|
| Synovial Membrane | 3 | 2016 | 54 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2020 | 170 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2019 | 46 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2020 | 165 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 420 | 0.150 |
Why?
|
| Arthralgia | 2 | 2016 | 134 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2016 | 42 | 0.130 |
Why?
|
| Interleukin-1 | 2 | 2013 | 48 | 0.130 |
Why?
|
| Organ Size | 1 | 2016 | 95 | 0.130 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 94 | 0.130 |
Why?
|
| Protein Kinase C-delta | 1 | 2016 | 10 | 0.130 |
Why?
|
| Axons | 1 | 2016 | 28 | 0.130 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2013 | 11 | 0.130 |
Why?
|
| Homeostasis | 2 | 2013 | 66 | 0.120 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 24 | 0.110 |
Why?
|
| Bone Development | 1 | 2014 | 32 | 0.110 |
Why?
|
| Bone Remodeling | 1 | 2014 | 50 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 1 | 0.110 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2013 | 1 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2020 | 520 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2013 | 14 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 30 | 0.110 |
Why?
|
| Cattle | 4 | 2013 | 130 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2013 | 102 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2012 | 4 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 21 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 110 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2013 | 130 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 599 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2016 | 374 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 271 | 0.080 |
Why?
|
| Humans | 7 | 2020 | 27074 | 0.080 |
Why?
|
| Proteoglycans | 3 | 2013 | 140 | 0.080 |
Why?
|
| Nerve Growth Factor | 2 | 2019 | 36 | 0.070 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 50 | 0.060 |
Why?
|
| Male | 1 | 2020 | 14772 | 0.050 |
Why?
|
| Organ Culture Techniques | 2 | 2013 | 12 | 0.050 |
Why?
|
| Female | 1 | 2020 | 15213 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 2 | 2013 | 19 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2020 | 4 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 37 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 124 | 0.040 |
Why?
|
| Synoviocytes | 1 | 2019 | 2 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 7 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2019 | 30 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2019 | 19 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 482 | 0.040 |
Why?
|
| Menisci, Tibial | 1 | 2020 | 174 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 673 | 0.040 |
Why?
|
| Receptor, trkA | 1 | 2016 | 10 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 2016 | 10 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2016 | 55 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2014 | 15 | 0.030 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 17 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 66 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 348 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2014 | 113 | 0.030 |
Why?
|
| Cell Line | 1 | 2014 | 273 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2014 | 84 | 0.030 |
Why?
|
| Macrophages | 1 | 2014 | 102 | 0.030 |
Why?
|
| Smad6 Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2013 | 9 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2013 | 9 | 0.030 |
Why?
|
| Alginates | 1 | 2013 | 11 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 40 | 0.030 |
Why?
|
| Cell Survival | 1 | 2013 | 121 | 0.030 |
Why?
|
| Collagen Type II | 1 | 2013 | 22 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 81 | 0.030 |
Why?
|
| Rabbits | 1 | 2013 | 182 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2013 | 21 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2013 | 149 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2013 | 58 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 36 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 59 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 66 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 42 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2012 | 16 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 25 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2012 | 40 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 34 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 67 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 75 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 222 | 0.020 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2012 | 80 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 272 | 0.020 |
Why?
|
| Knee Joint | 1 | 2016 | 753 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 8923 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 8997 | 0.020 |
Why?
|
| Adult | 1 | 2012 | 7831 | 0.010 |
Why?
|